Valuation: Gencurix Inc.

Market Cap 30.03B 19.6M 17.16M 15.81M 14.67M 27.86M 1.87B 28.24M 189M 73.64M 918M 73.59M 71.98M 3.18B P/E 2022
-1.86x
P/E 2023 -3.82x
Enterprise Value 35.66B 23.27M 20.38M 18.77M 17.43M 33.09M 2.22B 33.54M 225M 87.46M 1.09B 87.4M 85.48M 3.78B EV / Sales 2022
26.8x
EV / Sales 2023 34.6x
Free-Float
55.38%
Yield 2022 *
-
Yield 2023 -
1 day-14.35%
1 week-21.78%
Current month-22.31%
1 month-31.75%
3 months-28.77%
6 months+5.87%
Current year+10.44%
1 week 1,636
Extreme 1636
2,280
1 month 1,636
Extreme 1636
2,990
Current year 1,527
Extreme 1527
7,320
1 year 1,385
Extreme 1385
7,320
3 years 1,131
Extreme 1131
8,910
5 years 1,131
Extreme 1131
23,500
10 years 1,131
Extreme 1131
32,300
Manager TitleAgeSince
Chief Executive Officer 53 -
Chief Tech/Sci/R&D Officer 64 2014-12-31
Corporate Officer/Principal 61 2023-03-30
Director TitleAgeSince
Director/Board Member 53 -
Director/Board Member 61 2023-03-30
Director/Board Member 43 2023-09-12
Change 5-day change 1-year change 3-year change Capi.($)
-14.35%-21.78%-10.92%-45.53% 26.19M
+0.50%+9.81%+234.30%+364.30% 22.39B
-0.22%-0.43%-41.55%-24.07% 9.37B
-6.43%-6.17%+27.85%+26.30% 6.69B
-2.68%-2.78%-32.89% - 5.03B
-7.52%-4.72%-24.62%-33.28% 4.74B
+2.54%+7.67%+207.46%-24.49% 5.08B
0.00%+0.29%-22.29%-22.82% 4.25B
-4.73%-5.28%+73.33%+82.47% 3.9B
+0.35%+4.11%-17.16%-39.64% 2.62B
Average -3.25%-1.95%+39.35%+31.47% 6.41B
Weighted average by Cap. -1.37%+2.60%+92.99%+134.51%

Financials

2022 2023
Net sales 2.56B 1.67M 1.46M 1.35M 1.25M 2.37M 159M 2.41M 16.13M 6.28M 78.2M 6.27M 6.13M 271M 2.6B 1.7M 1.49M 1.37M 1.27M 2.41M 162M 2.45M 16.38M 6.38M 79.45M 6.37M 6.23M 275M
Net income -24.6B -16.05M -14.06M -12.95M -12.02M -22.82M -1.53B -23.13M -155M -60.32M -752M -60.28M -58.96M -2.61B -19.26B -12.57M -11.01M -10.14M -9.41M -17.87M -1.2B -18.11M -121M -47.23M -588M -47.2M -46.16M -2.04B
Net Debt 22.55B 14.71M 12.89M 11.87M 11.02M 20.92M 1.4B 21.21M 142M 55.3M 689M 55.26M 54.05M 2.39B 5.63B 3.68M 3.22M 2.97M 2.75M 5.23M 351M 5.3M 35.5M 13.81M 172M 13.8M 13.5M 597M
Logo Gencurix Inc.
Gencurix Inc. is a Korea-based company mainly engaged in the sale of medical equipments. In addition, the Company is involved in the manufacturing and sale of breast cancer test (BCT) kits, Korean genetic polymorphism diagnostic kits, lung cancer and colorectal cancer diagnostic kits. The BCT kits are used for analyzing the expression level of the cancer-related gene. The products are sold under the name of GenesWell.
Employees
-
Date Price Change Volume
26-07-06 ₩1,713.00 -14.35% 708,171
26-07-03 ₩2,000.00 -4.53% 302,880
26-07-02 ₩2,095.00 -3.68% 148,410
26-07-01 ₩2,175.00 -1.36% 200,674
26-06-30 ₩2,205.00 +0.68% 166,165
  1. Stock Market
  2. Stocks
  3. A229000 Stock